Liquid chromatography preparation method for separating minoxidil intermediate impurities and application thereof
Separation of impurities in minoxidil intermediates by liquid chromatography solves the problem of difficult impurities separation in the prior art, and achieves efficient separation and purification, ensuring the safety and effectiveness of the drug.
Patent Information
- Application Number
- CN202411143667.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art lacks effective methods for isolating and detecting impurities in minoxidil intermediates, affecting the purity and safety of the drug.
Compound B was separated from the minoxidil intermediate by liquid chromatography, and the mixture flow of methanol: water: acid was used to mix with preparative high-pressure liquid phase separation instrument. The phase was combined with the additive sodium sulfosuccinate dioctyl lipoxate and was eluted is equally elution to obtain a red-brown solid impurity.
It realizes efficient separation of minoxidil intermediate impurities, with a purity of more than 95%, and provides purified products for drug quality research, ensuring the safety and effectiveness of the drug.
Smart Images

Figure CN119059983A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of pharmaceutical chemical industry, in particular to a liquid chromatography preparation method for separating impurities of a minoxidil intermediate and application thereof. Background Art
[0002] Minoxidil, also known as Minoxidil or Long-pressure pyrimidine, is an organic compound with the chemical name 6-(1-piperidinyl)-2,4-pyrimidinediamine-3-oxide and the chemical formula C9H 15 N5O is a white crystalline powder. It is clinically used as a potassium channel opener. It can directly relax vascular smooth muscle and has a strong dilation effect on arterioles, which reduces peripheral resistance and blood pressure, but has no effect on capacitance vessels, so it can promote venous return. At the same time, due to the reflex regulation and positive frequency effect, it can increase cardiac output and heart rate, but does not cause postural hypotension. Studies in recent years have shown that in addition to treating vascular diseases, minoxidil can also be used to stimulate hair growth and the recovery of baldness, as well as to treat androgenic alopecia by increasing the synthesis of prostaglandin endoperoxides.
[0003] Drug impurities refer to substances in drugs that have no therapeutic effect or affect the stability and efficacy of drugs, or are even harmful to human health. In the research, production, storage and clinical application of drugs, the purity of drugs must be maintained and the impurities of drugs must be reduced in order to ensure the effectiveness and safety of drugs. Usually, the purity of drugs can be evaluated as an interrelated whole, including the structure, appearance, physicochemical constants, impurity inspection and content determination of drugs. Impurities contained in drugs are the main factors affecting drug purity. If the drug contains impurities exceeding the limit, it is possible to change the physicochemical constants, change the appearance, and affect the stability of the drug; the increase in impurities will inevitably reduce the content of the drug or reduce the activity, and significantly increase the toxic side effects. Therefore, the drug impurity detection room is a very important link in controlling the purity of drugs and improving the quality of drugs.
[0004]
[0005] The synthesis route of minoxidil can be divided into two main categories: the first category uses methyl cyanoacetate as the raw material, and the second category uses 2,4-diamino-6-chloropyrimidine as the starting material. Both process steps involve an important intermediate (compound A), which is condensed with piperidine to obtain the minoxidil API. After research, it was found that its chemical name 2,4-diamino-5,6-dichloropyrimidine-3-oxide (compound B) is a specific impurity of the intermediate and a by-product in the synthesis process. In addition, the separation degree between compound B and the starting material 2,4-diamino-6-chloropyrimidine (compound C) in liquid chromatography is very poor.
[0006] At present, there are many studies on the synthesis route of minoxidil, for example, Chinese patents CN113979952A, CN107235919A, CN107129470A, CN116425683A, CN117658925A and CN117247357A all report common methods for synthesizing minoxidil, and describe their synthesis processes. However, existing studies lack research on the synthesis and preparation methods of the impurities in the raw materials, intermediates and preparations of minoxidil. The present invention is a detection method and judgment basis for improving the production and medication safety of minoxidil. Summary of the invention
[0007] The technical problem to be solved by the present invention is to overcome the deficiencies in the prior art and provide a liquid chromatography preparation method for separating impurities of a minoxidil intermediate and its application. The preparation method of the present invention can ensure the effectiveness and safety of the drug, and the method is simple and efficient.
[0008] The technical solution adopted by the present invention to solve its technical problem is:
[0009] A liquid chromatography preparation method for separating impurities from a minoxidil intermediate, the preparation method specifically comprises the following steps of separating the impurity (compound B) from the minoxidil intermediate (compound A) by liquid chromatography:
[0010] Step S1, collecting the waste mother liquor of compound A produced in the process of minoxidil as a sample for use and processing;
[0011] Step S2, separation: taking the sample obtained in step S1, and treating it with a preparative high pressure liquid phase separation preparation instrument to obtain a preparation liquid, and the chromatographic conditions are as follows:
[0012] Instrument: preparative liquid chromatograph; chromatographic column: chromatographic column with octadecylsilane bonded silica gel as filler; methanol: water: acid are mixed in a volume ratio of (40:60:1) to (70:30:1), additives are added, and then mixed again as mobile phase for isocratic elution; flow rate 10ml / min to 25ml / min; wavelength 230nm to 280nm; column temperature 20℃ to 40℃; injection volume 0.5ml to 3.0ml;
[0013] Step S3: taking the prepared solution in step S2, enriching, concentrating and drying, and finally obtaining compound B.
[0014] The minoxidil intermediate impurity (compound B) is a reddish brown solid.
[0015] Furthermore, the waste mother liquor of compound A in step S1 is neutralized and concentrated, which is beneficial for subsequent separation.
[0016] Furthermore, the liquid chromatograph in step S2 is Agela HP100, and its parameter operation is conventional operation.
[0017] Furthermore, the chromatographic column in step S2 is an octadecylsilane bonded silica gel chromatographic column, Innova! 0DS-2, and the chromatographic column specification is 30 mm×250 mm, 5 μm.
[0018] Furthermore, in step S2, the volume ratio of methanol, water and acid in the mobile phase is 45:55:1.
[0019] Furthermore, the acid added to the mobile phase in step S2 is trifluoroacetic acid; and the additive is dioctyl sodium sulfosuccinate.
[0020] Furthermore, in step S2, the flow rate is 20 ml / min and the detection wavelength is 256 nm.
[0021] Furthermore, in step S2, the column temperature is 25° C.; an automatic sample injector is used, and the injection volume is 1.0 ml.
[0022] An application of the liquid chromatography preparation method for separating impurities in a minoxidil intermediate as described above, and the application of the liquid chromatography preparation method in preparing a minoxidil intermediate impurity B. Experimental results show that the obtained purified product can be used as an impurity reference substance for quality research of minoxidil intermediates and minoxidil raw materials, providing a guarantee for the safe use of minoxidil.
[0023] The beneficial effects of the present invention are as follows: the present invention is reasonably designed, the preparation method of the present invention is simple to operate and efficient, and the purity of the obtained compound monomer can reach more than 95%; using the separation and preparation method of the present invention, the impurities (compound B) in the minoxidil intermediate can be effectively prepared, and the specificity is good, and the target substance can be effectively separated. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0025] Figure 1 The liquid chromatogram of the waste mother liquor of the minoxidil intermediate after dilution in Example 1;
[0026] Figure 2 It is the liquid chromatogram of the minoxidil intermediate impurity (Compound B) in Example 1;
[0027] Figure 3 is the minoxidil intermediate impurity (compound B) in Example 1 1 H-NMR spectrum;
[0028] Figure 4 is the minoxidil intermediate impurity (compound B) in Example 1 13 C-NMR spectrum;
[0029] Figure 5 LC-MS spectrum of the minoxidil intermediate impurity (Compound B) in Example 1;
[0030] Figure 6 is a liquid chromatogram of the minoxidil intermediate impurity (Compound B) in Example 2;
[0031] Figure 7 It is the liquid chromatogram of the impurity of the minoxidil intermediate in Comparative Example 1;
[0032] Figure 8 It is the liquid chromatogram of the impurity of the minoxidil intermediate in Comparative Example 2;
[0033] Fig. 9 It is the liquid chromatogram of the impurity of minoxidil intermediate in comparative example 3. DETAILED DESCRIPTION
[0034] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.
[0035] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form also includes the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this description, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0036] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0037] The raw material minoxidil intermediate compound A used in the present invention is commercially available, and the other reagents used are also commercially available.
[0038] Example 1
[0039] A liquid chromatography preparation method for separating impurities of a minoxidil intermediate, specifically comprising:
[0040] A. Experimental Apparatus and Conditions
[0041] Instrument: Preparative high pressure liquid chromatography Agela HP100;
[0042] Chromatographic column: Innova! 0DS-2, 30 mm × 250 mm, 5 μm;
[0043] Detector: UV detector;
[0044] Elution method: isocratic elution;
[0045] Mobile phase: methanol-water-trifluoroacetic acid (45:55:1 v / v) (containing 2.0 g of dioctyl sodium sulfosuccinate per 1000 ml);
[0046] Column temperature: 20°C;
[0047] Flow rate: 20ml / min;
[0048] Injection volume: 1ml;
[0049] B. Experimental Procedure
[0050] Solution preparation: Take the waste mother liquor of the treated minoxidil intermediate, add 75% methanol to dissolve and dilute to a solution containing about 0.1 g per 1 ml;
[0051] Impurity preparation: collect the effluent at a wavelength of 256 nm, enrich and concentrate it, and then vacuum dry it to obtain the impurity.
[0052] Depend on Figure 1 It can be seen that the HPLC spectrum obtained for the diluted minoxidil intermediate waste mother liquor has 5 peaks, and compound B and compound C are difficult to separate in the HPLC. At the same time, the content of compound A is relatively high, and there are 2 peaks after compound C.
[0053] like Figures 2 to 5 As shown, the structure of the minoxidil intermediate impurity (Compound B) obtained in the above example was analyzed by nuclear magnetic resonance and mass spectrometry data: 1 H NMR (400MHz, DMSO-d6): δ7.81 (d, J = 119.8Hz, 4H); 13 C NMR (101MHz, DMSO-d6): δ151.93, 151.68, 142.97, 96.31; LC-MS (ESI) m / z: [M+H] +calcd for,C4H5Cl2N4O,195.0, found195.1.
[0054] It can be seen that the separation and preparation method of the present invention can effectively prepare the minoxidil intermediate impurity (compound B), the method has a high separation degree, and the purity of the impurity monomer is 99.85%.
[0055] Example 2
[0056] A liquid chromatography preparation method for separating impurities of a minoxidil intermediate, specifically comprising:
[0057] A. Experimental Apparatus and Conditions
[0058] Instrument: Preparative high pressure liquid chromatography Agela HP100;
[0059] Chromatographic column: Innova! 0DS-2, 30 mm × 250 mm, 5 μm;
[0060] Detector: UV detector;
[0061] Elution method: isocratic elution;
[0062] Mobile phase: methanol-water-trifluoroacetic acid (40:60:1 v / v) (containing 2.0 g of dioctyl sodium sulfosuccinate per 1000 ml);
[0063] Column temperature: 20°C;
[0064] Flow rate: 20ml / min;
[0065] Injection volume: 1ml;
[0066] B. Experimental Procedure
[0067] Solution preparation: Take the waste mother liquor of the treated minoxidil intermediate, add 75% methanol to dissolve and dilute to a solution containing about 0.1 g per 1 ml;
[0068] Impurity preparation: collect the effluent at a wavelength of 256 nm, enrich and concentrate it, and then dry it in vacuum to obtain the impurity, HPLC: 98.85%.
[0069] By Figure 6 It can be seen from the HPLC spectrum obtained in the above embodiment that the separation and preparation method of this embodiment can be used for elution, and the minoxidil intermediate impurity (compound B) can be effectively prepared, but the impurities separated by the eluent ratio contain a small amount of compound A, and the purity of the impurity monomer is 98.85%.
[0070] Comparative Example 1
[0071] A liquid chromatography preparation method for separating impurities of a minoxidil intermediate, specifically comprising:
[0072] A. Experimental Apparatus and Conditions
[0073] Instrument: Preparative high pressure liquid chromatography Agela HP100;
[0074] Chromatographic column: Innova! 0DS-2, 30 mm × 250 mm, 5 μm;
[0075] Detector: UV detector;
[0076] Elution method: isocratic elution;
[0077] Mobile phase: methanol-water-trifluoroacetic acid (10:90:1 v / v) (containing 2.0 g of dioctyl sodium sulfosuccinate per 1000 ml);
[0078] Column temperature: 20°C;
[0079] Flow rate: 20ml / min;
[0080] Injection volume: 1ml;
[0081] B. Experimental Procedure
[0082] Solution preparation: Take the waste mother liquor of the treated minoxidil intermediate, add 75% methanol to dissolve and dilute to a solution containing about 0.1 g per 1 ml.
[0083] Impurity preparation: collect the effluent at a wavelength of 256 nm, enrich and concentrate it, and then vacuum dry it to obtain the impurities.
[0084] By Figure 7 It can be seen from the HPLC spectrum obtained in this comparative example that the separation and preparation method of this example cannot effectively elute the target compound and no solid is obtained, indicating that the preparation and separation method of the present invention is obtained through screening and optimization.
[0085] Comparative Example 2
[0086] A liquid chromatography preparation method for separating impurities of a minoxidil intermediate, specifically comprising:
[0087] A. Experimental Apparatus and Conditions
[0088] Instrument: Preparative high pressure liquid chromatography Agela HP100;
[0089] Chromatographic column: Innova! 0DS-2, 30 mm × 250 mm, 5 μm;
[0090] Detector: UV detector;
[0091] Elution method: isocratic elution;
[0092] Mobile phase: methanol-water-trifluoroacetic acid (70:30:1 v / v) (containing 2.0 g of dioctyl sodium sulfosuccinate per 1000 ml);
[0093] Column temperature: 20°C;
[0094] Flow rate: 20ml / min;
[0095] Injection volume: 1ml;
[0096] B. Experimental Procedure
[0097] Solution preparation: Take the waste mother liquor of the treated minoxidil intermediate, add 75% methanol to dissolve and dilute to a solution containing about 0.1 g per 1 ml;
[0098] Impurity preparation: collect the effluent at a wavelength of 256 nm, enrich and concentrate it, and then vacuum dry it to obtain the impurity.
[0099] By Figure 8 It can be seen from the HPLC spectrum obtained in this comparative example that the substance obtained by the separation and preparation method of this comparative example is not the target substance (Compound B) nor the substance in the sample solution when detected by HPLC, so it is speculated that the change in the mobile phase ratio causes the substance to react with the environment in the preparative liquid phase instrument, thereby obtaining the substance. Therefore, it is further explained that the preparative separation method of the present invention is obtained through screening and optimization.
[0100] Comparative Example 3
[0101] A liquid chromatography preparation method for separating impurities of a minoxidil intermediate, specifically comprising:
[0102] A. Experimental Apparatus and Conditions
[0103] Instrument: Preparative high pressure liquid chromatography Agela HP100;
[0104] Chromatographic column: Innova! 0DS-2, 30 mm × 250 mm, 5 μm;
[0105] Detector: UV detector;
[0106] Elution method: isocratic elution;
[0107] Mobile phase: methanol-water-trifluoroacetic acid (45:55:1 v / v)
[0108] Column temperature: 20°C;
[0109] Flow rate: 20ml / min;
[0110] Injection volume: 1ml.
[0111] B. Experimental Procedure
[0112] Solution preparation: Take the waste mother liquor of the treated minoxidil intermediate, add 75% methanol to dissolve and dilute to a solution containing about 0.1 g per 1 ml.
[0113] Impurity preparation: collect the effluent at a wavelength of 256 nm, enrich and concentrate it, and then vacuum dry it to obtain the impurity.
[0114] By Fig. 9 It can be seen from the HPLC spectrum obtained in this comparative example that the substance obtained by the separation and preparation method of this comparative example is not the target substance (Compound B) nor the substance in the sample solution when detected by HPLC. Therefore, it is speculated that the substance is obtained by reacting with the test environment in the preparative liquid phase instrument due to the lack of addition of sodium sulfosuccinate dioctyl fat. Therefore, it is further explained that the preparation and separation method of the present invention is obtained through screening and optimization.
[0115] In summary, the present invention is reasonably designed, the preparation method of the present invention is simple to operate and efficient, and the purity of the obtained compound monomer can reach more than 95%; using the separation and preparation method of the present invention, the impurity (compound B) in the minoxidil intermediate can be effectively prepared, and the specificity is good, and the target substance can be effectively separated.
[0116] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A liquid chromatography preparation method for separating impurities of minoxidil intermediates, characterized in that: The preparation method specifically comprises separating the impurity compound B from the minoxidil intermediate compound A by liquid chromatography, and specifically comprises the following steps: Step S1, collecting the waste mother liquor of compound A produced in the process of minoxidil as a sample for use and processing; Step S2, separation: taking the sample obtained in step S1, and treating it with a preparative high pressure liquid phase separation preparation instrument to obtain a preparation liquid, and the chromatographic conditions are as follows: Instrument: preparative liquid chromatograph; Chromatographic column: a chromatographic column with octadecylsilane bonded silica gel as filler; Methanol: water: acid are mixed in a volume ratio of (40:60:1) to (70:30:1), and then the additive is added and mixed again as the mobile phase for isocratic elution; flow rate 10ml / min to 25ml / min; wavelength 230nm to 280nm; column temperature 20℃ to 40℃; injection volume 0.5ml to 3.0ml; Step S3: taking the prepared solution in step S2, enriching, concentrating and drying, and finally obtaining compound B.
2. A liquid chromatography preparation method for separating impurities of a minoxidil intermediate according to claim 1, characterized in that: The waste mother liquor of compound A in step S1 is neutralized and concentrated, which is beneficial for subsequent separation.
3. A liquid chromatography preparation method for separating impurities of minoxidil intermediates according to claim 1, characterized in that: The liquid chromatograph in step S2 is Agela HP100, and its parameter operation is conventional operation.
4. A liquid chromatography preparation method for separating impurities of minoxidil intermediates according to claim 1, characterized in that: The chromatographic column in step S2 is an octadecylsilane bonded silica gel chromatographic column, Innova! 0DS-2, and the chromatographic column specification is 30 mm×250 mm, 5 μm.
5. A liquid chromatography preparation method for separating impurities of a minoxidil intermediate according to claim 1, characterized in that: In step S2, the volume ratio of methanol, water and acid in the mobile phase is 45:55:
1.
6. A liquid chromatography preparation method for separating impurities of a minoxidil intermediate according to claim 1, characterized in that: The acid added to the mobile phase in step S2 is trifluoroacetic acid; the additive is dioctyl sodium sulfosuccinate, and the mass of dioctyl sodium sulfosuccinate in every 1000 ml of mobile phase is 2.0 g.
7. A liquid chromatography preparation method for separating impurities of a minoxidil intermediate according to claim 1, characterized in that: In step S2, the flow rate is 20 ml / min and the detection wavelength is 256 nm.
8. A liquid chromatography preparation method for separating impurities of a minoxidil intermediate according to claim 1, characterized in that: In step S2, the column temperature is 25° C.; an automatic sample injector is used, and the injection volume is 1.0 ml.
9. An application of the liquid chromatography preparation method for separating impurities of a minoxidil intermediate as claimed in any one of claims 1 to 8, characterized in that: Application of the liquid chromatography preparation method in the preparation of minoxidil intermediate impurity B.
